Clinical Trials Logo

Clinical Trial Summary

The degree of suppression and subsequent activation of the hypothalamic-pituitary-ovarian axis during the hormone-free interval in combined oral contraceptive (COC) hormone users varies depending on the dose of ethinyl estradiol in the formulation. This variation in activation may be associated with different side effects during the hormone free interval. Progesterone (P) remained suppressed during all 6 COC regimens (<1.8 ng/mL), which indicates continuous contraceptive efficacy during the 7-day hormone free interval of all formulations studied.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Hypothalamic-pituitary-ovarian Axis, Gonadotropins, Ethinyl Estradiol, Contraceptive Efficacy
  • Pituitary Diseases

NCT number NCT01953211
Study type Observational
Source University of Southern California
Contact
Status Completed
Phase